Looking for free oshun griot apps? 20 of our 250+ tracked titles are free to download — no subscription, no trial. The rest are premium picks worth paying for.
This app offers a holistic and culturally-centered approach to infertility support, particularly for people of color. It provides educational resources, community stories, and wellness tools to empower individuals navigating their reproductive health journey.
This app serves as a personal portal for individuals undergoing fertility treatments. It allows users to complete forms, receive notifications, access educational content, view donor profiles, message their medical team, and track their personalized journey.
Track your menstrual cycle, fertility, pregnancy, postpartum recovery, and menopause with personalized insights and expert articles. This app offers tools for ovulation prediction, baby growth tracking, and symptom management.
Oshun Griot tops our oshun griot apps ranking as of September 2026, with a 5.0-star average from 3 App Store ratings, and it's free to download.
Are there free oshun griot apps for iPhone?
Yes — 20 of the top oshun griot apps we rank are free to download, including Oshun Griot and Ivy Fertility Patient Journey.
Does Oshun Griot have ads or in-app purchases?
Oshun Griot has no ads and offers in-app purchases, according to its App Store listing as of September 2026.
How many oshun griot apps are on the App Store?
We track 250+ oshun griot apps on the iOS App Store as of September 2026, ranked by rating, recency, and analysis of real user reviews.
What is Oshun Griot?
Oshun Griot is a holistic, culturally-centered companion app designed to support individuals and families navigating infertility, IVF, and reproductive wellness. It offers educational resources, emotional support, and community wisdom.
What kind of content does Oshun Griot offer?
Oshun Griot provides educational articles on topics like IVF, endometriosis, and PCOS, expert-led videos, daily affirmations, mind-body wellness resources, and community stories from others facing similar challenges.